Literature DB >> 36264352

Quantification and Proximal-to-Distal Distribution Pattern of Tibial Nerve Lesions in Relapsing-Remitting Multiple Sclerosis : Assessment by MR Neurography.

Adriana M Pietsch1,2, Andrea Viehöver3, Ricarda Diem3, Markus Weiler3, Mirjam Korporal-Kuhnke3, Brigitte Wildemann3, Georges Sam3, John M Hayes4, Olivia Fösleitner1, Johann M E Jende1, Sabine Heiland5, Martin Bendszus1, Jennifer C Hayes6.   

Abstract

PURPOSE: Recent studies suggest an involvement of the peripheral nervous system (PNS) in multiple sclerosis (MS). Here, we characterize the proximal-to-distal distribution pattern of peripheral nerve lesions in relapsing-remitting MS (RRMS) by quantitative magnetic resonance neurography (MRN).
METHODS: A total of 35 patients with RRMS were prospectively included and underwent detailed neurologic and electrophysiologic examinations. Additionally, 30 age- and sex-matched healthy controls were recruited. 3T MRN with anatomical coverage from the proximal thigh down to the tibiotalar joint was conducted using dual-echo 2‑dimensional relaxometry sequences with spectral fat saturation. Quantification of PNS involvement was performed by evaluating microstructural (proton spin density (ρ), T2-relaxation time (T2app)), and morphometric (cross-sectional area, CSA) MRN markers in every axial slice.
RESULTS: In patients with RRMS, tibial nerve lesions at the thigh and the lower leg were characterized by a decrease in T2app and an increase in ρ compared to controls (T2app thigh: p < 0.0001, T2app lower leg: p = 0.0040; ρ thigh: p < 0.0001; ρ lower leg: p = 0.0098). An additional increase in nerve CSA was only detectable at the thigh, while the semi-quantitative marker T2w-signal was not altered in RRMS in both locations. A slight proximal-to-distal gradient was observed for T2app and T2-signal, but not for ρ.
CONCLUSION: PNS involvement in RRMS is characterized by a decrease in T2app and an increase in ρ, occurring with proximal predominance at the thigh and the lower leg. Our results indicate microstructural alterations in the extracellular matrix of peripheral nerves in RRMS and may contribute to a better understanding of the pathophysiologic relevance of PNS involvement.
© 2022. The Author(s).

Entities:  

Keywords:  Magnetic resonance neurography; Peripheral nervous system; Proton spin density; Quantitative imaging markers; T2-relaxometry

Year:  2022        PMID: 36264352     DOI: 10.1007/s00062-022-01219-1

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN: 1869-1439            Impact factor:   3.156


  51 in total

1.  Peripheral neuropathy in multiple sclerosis.

Authors:  J HASSON; R D TERRY; H M ZIMMERMAN
Journal:  Neurology       Date:  1958-07       Impact factor: 9.910

Review 2.  How reliable is the classification of cognitive impairment across different criteria in early and late stages of multiple sclerosis?

Authors:  Martin Fischer; Annett Kunkel; Peter Bublak; Jürgen H Faiss; Frank Hoffmann; Michael Sailer; Matthias Schwab; Uwe K Zettl; Wolfgang Köhler
Journal:  J Neurol Sci       Date:  2014-05-27       Impact factor: 3.181

Review 3.  The natural history of multiple sclerosis: update 1998.

Authors:  B G Weinshenker
Journal:  Semin Neurol       Date:  1998       Impact factor: 3.420

4.  'Onion bulb' formations in the central and peripheral nervous system in association with multiple sclerosis and hypertrophic polyneuropathy.

Authors:  W C Schoene; S Carpenter; P O Behan; N Geschwind
Journal:  Brain       Date:  1977-12       Impact factor: 13.501

5.  Peripheral nerve abnormality in multiple sclerosis.

Authors:  M Pollock; C Calder; S Allpress
Journal:  Ann Neurol       Date:  1977-07       Impact factor: 10.422

6.  The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course.

Authors:  B G Weinshenker; B Bass; G P Rice; J Noseworthy; W Carriere; J Baskerville; G C Ebers
Journal:  Brain       Date:  1989-12       Impact factor: 13.501

Review 7.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Authors:  Alan J Thompson; Brenda L Banwell; Frederik Barkhof; William M Carroll; Timothy Coetzee; Giancarlo Comi; Jorge Correale; Franz Fazekas; Massimo Filippi; Mark S Freedman; Kazuo Fujihara; Steven L Galetta; Hans Peter Hartung; Ludwig Kappos; Fred D Lublin; Ruth Ann Marrie; Aaron E Miller; David H Miller; Xavier Montalban; Ellen M Mowry; Per Soelberg Sorensen; Mar Tintoré; Anthony L Traboulsee; Maria Trojano; Bernard M J Uitdehaag; Sandra Vukusic; Emmanuelle Waubant; Brian G Weinshenker; Stephen C Reingold; Jeffrey A Cohen
Journal:  Lancet Neurol       Date:  2017-12-21       Impact factor: 44.182

Review 8.  Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management.

Authors:  Sophie G Fletcher; Wanda Castro-Borrero; Gina Remington; Katherine Treadaway; Gary E Lemack; Elliot M Frohman
Journal:  Nat Clin Pract Urol       Date:  2009-02

9.  Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study.

Authors:  J H Faiss; D Dähne; K Baum; R Deppe; F Hoffmann; W Köhler; A Kunkel; A Lux; M Matzke; I K Penner; M Sailer; U K Zettl
Journal:  BMJ Open       Date:  2014-04-10       Impact factor: 2.692

10.  Defining the clinical course of multiple sclerosis: the 2013 revisions.

Authors:  Fred D Lublin; Stephen C Reingold; Jeffrey A Cohen; Gary R Cutter; Per Soelberg Sørensen; Alan J Thompson; Jerry S Wolinsky; Laura J Balcer; Brenda Banwell; Frederik Barkhof; Bruce Bebo; Peter A Calabresi; Michel Clanet; Giancarlo Comi; Robert J Fox; Mark S Freedman; Andrew D Goodman; Matilde Inglese; Ludwig Kappos; Bernd C Kieseier; John A Lincoln; Catherine Lubetzki; Aaron E Miller; Xavier Montalban; Paul W O'Connor; John Petkau; Carlo Pozzilli; Richard A Rudick; Maria Pia Sormani; Olaf Stüve; Emmanuelle Waubant; Chris H Polman
Journal:  Neurology       Date:  2014-05-28       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.